Hadi Karami
9PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Dec 11, 2025
The Isoflavone Formononetin Suppresses Hallmarks of Glioblastoma Progression and Activates a Compensatory Antioxidant Pathway.Fatemeh Dinarvand, Mehdi Salehi, Seyyed Amirhossein Latifi
|Jul 28, 2022
Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells.Behzad Baradaran, Roya Nazmabadi, Zohreh Ariyan
|Dec 30, 2021
Combination Therapy with PIK3R3-siRNA and EGFR-TKI Erlotinib Synergistically Suppresses Glioblastoma Cell Growth In Vitro.Razieh Amini, Hadi Karami, Mohammad Bayat
|Jul 28, 2021
MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells.Nooshin Ashofteh, Razieh Amini, Neda Molaee
|Jun 28, 2020
MiRNA-7 Replacement Effect on Proliferation and Tarceva-Sensitivity in U373-MG Cell Line.Vahab Alamdari-Palangi, Zahra Karami, Hadi Karami
|Mar 28, 2020
Gene Therapy with MiRNA-Mediated Targeting of Mcl-1 Promotes the Sensitivity of Non-Small Cell Lung Cancer Cells to Treatment with ABT-737.Mahshid Shahverdi, Razieh Amini, Jamal Amri
Pageof 2
